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Abstract: The present work aimed at assessing the pharmaceutical tableting properties of some
Egyptian kaolin samples belong to the Abu Zenima kaolin deposits (estimated at 120 million
tons). Four representative samples were selected based on kaolinite richness and their structural
order-disorder degree, and after purification, they were dried at 70 ◦C and heated from room
temperature up to 400 ◦C (10 ◦C/min). Mineralogy, micromorphology, microtexture, granulometry,
porosimetry, moisture content, bulk and tapped density, direct and indirect flowability, and tableting
characteristics are studied. Results indicated that purified kaolin samples were made up of 95–99%
kaolinite, <3% illite, 1% quartz and 1% anatase. The powder showed mesoporous character (pore
diameters from 2 to 38 nm and total pore volume from 0.064 to 0.136 cm3/g) with dominance of fine
nanosized particles (<1 µm–10 nm). The powder flow characteristics of both the ordered (Hinckley
Index HI > 0.7, crystallite size D001 > 30 nm) and disordered (HI < 0.7, D001 < 30 nm) kaolinite-rich
samples have been improved (Hausner ratio between 1.24 and 1.09) as their densities were influenced
by thermal treatment (with some observed changes in the kaolinite XRD reflection profiles) and
by moisture content (variable between 2.98% and 5.82%). The obtained tablets exhibited hardness
between 33 and 44 N only from the dehydrated powders at 400 ◦C, with elastic recovery (ER) between
21.74% and 25.61%, ejection stress (ES) between 7.85 and 11.45 MPa and tensile fracture stress (TFS)
between 1.85 and 2.32 MPa, which are strongly correlated with crystallinity (HI) and flowability (HR)
parameters. These findings on quality indicators showed the promising pharmaceutical tabletability
of the studied Egyptian kaolin powders and the optimization factors for their manufacturability
and compactability.
Keywords: Egyptian kaolin; powder; microstructure; micrometrics; flowability; tableting properties;
manufacturability; table hardness
1. Introduction
Tablets represent about 75% of all the common orally administered solid dosage forms. Powder
flowability of tableting excipients is one of the most important quality-by-design properties that must
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be highly adequate because it directly controls the powder transport and tableting characteristics as
well as tablet content and dosage uniformity [1]. Kaolinite is the major and common-forming mineral
of the sedimentary kaolin deposits, representing the most widely distributed resources and occurrences
when compared to those of its kaolin group-polymorph halloysite. Kaolinite is a generally inexpensive,
ubiquitous and biologically safe raw geomaterial to be used in pharmaceutical formulations at specific
high purity grades. This phyllosilicate mineral exhibits a simple pseudohexagonal platy-form of
stacking layered structure, with excellent physical and chemical properties that make it suitable as
excipient (e.g., diluent, binder, disintegrant, pelletizing, granulating, amorphizing and film coating,
emulsifying and suspending agents and drug carrier) in solid and semi-solid dosage formulations,
besides its therapeutic activity in many biomedicinal applications [2–13]. Kaolinite particles and
its polymorph halloysite nanotubes surfaces exhibit adsorption affinities to many active ingredients
including the organic drug and agrochemical molecules, biomolecules and non-toxic bioactive
metals [14–17]. Moreover, developmental studies by Tan et al. [18] and Dey et al. [19] on the kaolinite
functionality as pharmaceutical carrier reported that the drug loading capacities and controlled release
by this clay mineral can be improved by means of physical and chemical modifications, as well as by
hybridation with biopolymers [20–22]. In additions, some important natural and modified microporous
aluminosilicate minerals (e.g., zeolite and phillipsite) have been proved excellent functionalities in the
drug loading and controlled release as pharmaceutical carrier and hence they are compatible with
kaolin minerals for solid dosage formulations [23–29].
Kaolinite is a good compactible mineral that is chemically inert and compatible to bind physically
with many other adjuvant substances used in solid dosage formulations. The equilibrium moisture
content (EMC) is a physical parameter used to classify pharmaceutical solid excipients based on the
relative absorbed and/or adsorbed water amounts by a specific constant mass of each material at
the same equilibrium ambient conditions, including storage time, temperature, humidity, etc. [30].
Kaolinite is a weakly hygroscopic mineral as it exhibits very low EMC (<1%), and it is desirable
in tablets manufacturing when compared to other strongly hygroscopic clay and non-clay minerals
because high moisture contents which exist as confined pore fluids influence undesirably on the
performance and efficiency of powder flowability and compressibility during tablet manufacturing,
affecting the physical stability of the compressed particles and the chemical stability of the active
ingredient in the final tablet product during storage [31,32]. Moreover, kaolinite exhibits the highest
chemical stability against acid attack amongst all clay minerals; therefore it is highly gastric acid
resistant and preferred for oral dosage formulations, particularly in antacid products [8,33,34].
In high purity kaolin grade, the most variable and modifiable technological properties that generally
control the applicability and quality of kaolinite as excipient material in pharmaceutical solid and
semisolid formulations are the structural, micromorphological and microtextural characteristics [35–37],
particularly the kaolinite platelets stacking order-disorder degree and its average coherent thickness,
i.e., crystallite size, porosity, particle shape, particle-particle interaction and packing pattern, particle
size granulometry and the uniformity or heterogeneous grading character of the kaolin powder [38,39].
Therefore, flowability properties are high probably influenced by these powder characteristics,
which could affect the performance and efficiency of tablets manufacturing and their physical and
physicochemical stability during storage. For these reasons, the mentioned factors must be taken
in consideration while the developmental and optimization studies on the kaolinite-based solid
dosage formulations.
The Gamlen® D-series powder compaction analyzer is one of the most advanced and high-
performance instrument used in powder compaction analysis and characterization for tablet
manufacturing based on quality by design (QbD) approach [40]. Generally, only the halloysite
tableting properties, amongst all the clay minerals, were recently characterized by means of this
method [41]. The kaolinite resources of Abu Zenima district, located at west central Sinai in Egypt
(estimated at 120 million tons), have recently received attention for evaluation and exploitation in
pharmaceutical uses [38]. In the present study, the tableting properties of some representative high
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grade samples of Egyptian kaolins have been characterized by powder compaction analysis following
the method of Osamura et al. [42] for evaluating their potentiality and performance as pharmaceutical
excipient, checking the effects of their particle micrometrics and powder geometrical characteristics
as quality controlling factors on the tableting properties. Basically, the study aims to compare the
flow and tableting behaviors of these kaolinite-rich samples with the changes of moisture contents,
microstructures and micrometrics after thermal treatment at low (70 ◦C) and high (400 ◦C) temperatures.
2. Materials and Methods
2.1. Materials and Preparation
Four representative high-grade (i.e., high purity and quality) raw kaolinite-rich samples (named
N-2, F-2, D-6 and K-3) with variable structural ordered-disordered degrees were selected for testing
and evaluation of their tableting characteristics and powder flowability. These samples belong to the
economically viable Egyptian Abu Zenima kaolin deposits, characterized mineralogically, chemically
and proved suitability for pharmaceutical uses according to specifications and limits reported in kaolin
monograph of the European and US Pharmacopoeias and the European Medicines Agency [38].
The raw samples were crushed, milled, dried and sieved to particle size <125 µm. Then, samples
were subjected to purification following the sedimentation method of Maynard [43]. Kaolin
particles were disaggregated by using mechanical stirrer with the addition of a dispersant, sodium
hexametaphosphate (conc. 0.75%), to keep the particles flocculated and preventing their agglomeration,
due to the increase of the particles repulsion by increasing the negative charge on mineral surfaces.
The pH was adjusted to the range 6.5 to 7.0 by using sodium carbonate (conc. 0.25%) to induce
the negative charge on both edges and faces of kaolinite particles [44]. The slurry was then kept to
settling for 24 h, and then subjected to decantation process. The whiter decanted dispersions were
centrifuged and washed three times, then dried and the powders were kept to perform the targeted
characterizations of the present study, while the darker settled layers of the coarser silt-sized kaolin
particles (>44 µm) with mineral impurities were dried, re-pulverized and recovered.
Thermodynamically, the desorption enthalpy (i.e., energy required for water desorption) increases
with decreasing of the equilibrium moisture content. Hence, the intrinsic low equilibrium moisture
content of kaolins requires rising of temperatures during the drying process. Clearly, the optimum
temperature for the complete desorption of the unbounded water (i.e., the free moisture content that
can be easily removed) has been determined experimentally from the moisture sorption isotherms of
kaolin as 70 ◦C [45]. Meanwhile, a higher energy is required to the complete desorption of the bounded
water (i.e., that is more difficult to remove in practice) which is possible by heating up to 400 ◦C with
keeping on the kaolinite chemical stability without decomposition. Therefore, the studied purified four
samples were fractionated into two testable categories: the first one was dried at 70 ◦C for 2 h in dryer
oven (to easily remove the free unbounded water content), and the other was heated by the rate of
10 ◦C/min from the room temperature up to 400 ◦C in a temperature controlling furnace (to remove the
bounded water content). Then, all the samples were kept in desiccators at the same conditions. Hence,
the study would be focused mainly on testing the influence of desorbing confined pore water on the
potential improvement of kaolin powder flowability and enhancing successful tableting behaviors.
2.2. Powder Characterization
2.2.1. XRD/XRF Composition and Microstructure
The purified kaolin samples were analyzed by means of X-ray diffraction (XRD) and X-ray
fluorescence (XRF) by following the same methods described in Awad et al. [38]. The XRD analysis was
performed by using an X’Pert Pro diffractometer (CuKα radiation, 45 kV, 40 mA, Malvern PANalytical
Ltd, Malvern, UK) equipped with an X’Celerator solid-state linear detector (Malvern PANalytical Ltd,
Malvern, UK), using a step increment of 0.008◦ 2θ and a counting time of 10 s/step. The XRF analysis
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was carried out on prepared pressed pellets samples by using a commercial wavelength dispersive
X-ray fluorescence instrument (S4 Pioneer, Bruker AXS Inc., Fitchburg, WI, USA) equipped with an Rh
anode X-ray tube (60 KV, 150 mA) and linked to SpectraPlus software (SpectraPLUS-DT, Pioneer Hill
Software LLC., Poulsbo, WA, USA). The loss on ignition (LOI) was determined by samples heating to
900 ◦C for 1 h.
The mineralogical composition was determined by combination of XRD and chemical analysis
data following the methods of Moore and Reynolds [46] and López-Galindo et al. [47].The scanned
diffraction data of the 020, 0-10 and 11-1 reflections (from 19◦ to 24◦ 2θ) were used for determining
kaolinite structural order-disorder degree by means of Hinckley Index (HI [48]) and those of the
001 reflection (from 11◦ to 13.5◦ 2θ) were used for determining their crystallite sizes (D001) by using
the XPOWDER® software (XPOWDER12, UGR, Granada, Spain [49], which was calculated by means
of reflection profile broadening analysis based on the Warren modification of the Scherrer equation as
explained in Awad et al. [39].
2.2.2. SEM/TEM Microtexture and Micromorphology
Microtexture of kaolinite particles was imaged by field emission scanning electron microscopy
(FESEM) by using a SUPRA40VP instrument (Carl Zeiss, Jena, Germany) working at 5 to10 kV.
The kaolinite particle morphology was investigated by means of transmission electron microscopy by
using a Titan G2 60-300 microscope (FEI, Hillsboro, OR, USA) with a high brightness electron gun
(X-FEG) operated at 300 kV and equipped with a SUPER-X silicon-drift window-less EDX detector.
The spectra were collected in STEM mode using a HAADF detector (Gatan Inc., Pleasanton, CA, USA).
2.2.3. Laser Granulometry
Granulometric analysis of the purified kaolin samples were performed by using a laser diffraction
technique (Mastersizer 2000LF, Malvern Instruments, Malvern, UK) in the particle size range between
0.02 and 1500 µm. The instrument is consisted of a wet sample dispersion unit (Hydro MU, Malvern
Instruments, Malvern, UK) and microvolume wet sampler (Hydro 200Up, Malvern Instruments,
Malvern, UK) connected to optical bench equipped by light scattering patterns detectors. Prior to the
measurement, a few milligrams of the powder sample (<125 µm) were fed into the dispersion unit to
the correct concentration for stirring in purified water with sonification for 30 s and then delivered to
the optical bench for measurement based on a standard operating procedure. The captured raw data
were analyzed and visualized automatically by the Malvern software.
2.2.4. Porosity
The Barrett, Joyner and Halenda (BJH) cumulative pore volumes (cm3/g) between 1.7 and 300 nm
diameters of the studied kaolin samples were determined by N2 adsorption/desorption isotherms
based on the Brunauer–Emmett–Teller (BET) method. The N2 sorption isotherms were obtained by
using a Micromeritics TriStar 3000 (Micromeritics Instrument Corporation, Norcross, GA, USA) under
continuous adsorption conditions at 77.300 K. Before measurement, powder samples were heated
at 200 ◦C for 2 h and outgassed to 10−3 Torr using a Micromeritics Flowprep (flow prep station 060,
Micromeritics Instr. Corp., Norcross, GA, USA) [50].
2.2.5. Bulk and Tapped Density
The densities of the studied kaolin samples were measured for the two described categories of
powder’s heating conditions. The bulk and tapped densities were determined following the method
(A) in the d ocument number QAS/11-450 [51] of the international pharmacopeia. A 5 g of each fraction
sample passed through 125 µm sieve apertures to break up agglomerates that may formed during
storage and poured into a dry 10 mL graduated cylinder (readable to 1 mL) and leveled at fixed
specific initial volume (V0 = 6 mL) without compacting. The mass (m) of the fixed powder volume was
weighted with 0.0001g accuracy and the bulk densities (d0 in g/mL) calculated by using the formula
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m/V0. The tapped density (dc in g/mL) was calculated by the formula m/Vc, where Vc is the compaction
volume obtained after mechanical tapping of the bulk volume (V0), achieved by STAV 2003 Stampf
volumeter (Engelsmann, Laborgerätebörse GmbH, Bruckstr, Burladingen, Germany) for c = 1250 taps.
This number of taps (c = 1250) was considered as the optimum tapped volume because the determined
difference between V500 and V1250 for each measured sample was <2 mL and even the difference
between V1250 and V2500 was insignificant. Triplicate measurements were carried out for both density
types to calculate median and standard deviation.
2.2.6. Thermogravimetric Analysis (TGA)
The thermogravimetric analysis was carried out on the studied kaolin samples within the thermal
range ~25 ◦C to ~1000 ◦C (temperature rising rate of 10 ◦C/min). It was performed on 10 mg of each
sample in a platinum mesh cell (crucible) by using a Shimadzu TGA-50H thermogravimetric analyzer
(Shimadzu Corporation, Kyoto, Japan) with vertical oven design and maximum precision of 0.001 mg,
and the collected data were processed by using TA-60WS Thermal Analysis Workstation Software
(TA-60WS 2.21, developed by Shimadzu Corp., Kyoto, Japan) equipped with the OLE function and
ASCII conversion function. Before measurements, the temperature was calibrated and the TG data
were corrected as the buoyancy effects and disturbances were eliminated. The targeted moisture
contents of the studied samples were determined from the original TGA curves by means of the mass
loss% obtained only within the focused heating range from room temperature (~25 ◦C) up to 400 ◦C.
2.2.7. Powder Flowability
Flowability of the studied kaolin powders was determined by means of direct and indirect
methods. For the direct flowability (g/s), 15 g of each powder sample was poured into the funnel
of a flow meter equipment (GDT Erweka, Heusenstamm, Hesse, Germany, [52]) and the time taken
through powder flowing was detected automatically and accurately with triplicate measurements.
Indirect flowability methods were determined for both of the two cited conditions of powder heating
(70 ◦C and 400 ◦C) and calculated based on the bulk and tapped density values by means of the flow
parameters, Hausner ratio (HR = V0/Vc, [53]) and Compressibility Index, also known as Carr’s index
(CI = 100[(V0 − Vc)/V0], [54]).
2.3. Tablets Manufacturing and Testing Data Analysis
The manufacturing of kaolin tablets for evaluating their tableting potential and performance
properties (compressibility, compactability and manufacturability) was performed by using the Gamlen
Tablet Press (GTP-1, Gamlen® Instruments, Croydon, London, UK) benchtop single-punch tablet
press) [40,55,56]. The tablets were prepared in three steps: (1) after the settings adjustment and
calibration (base plate position = 28.348 mm) procedure, a 100 mg of each powder sample (heated
up to 400 ◦C) was poured into the funnel of the die (diameter value was set as 6 mm) in the correct
compaction base position and the filled die inserted onto the cradle and locked to the compression
position; then the upper punch was moved downwards at a fixed speed (60 mm/min) for compaction
at a load of 500 kg with a flat punch of diameter 6 mm; (2) after compaction, the punch moved
upwards, then the lock released and the die cradle was rotated vertically to the detachment position;
and (3) by completing the detachment, the die cradle was returned horizontally with the correct die
base position for tablet ejection. The force (kg) and displacement (mm) data were measured for all
the compaction, detachment and ejection processes in seven replicates for each sample (the total was
28 tablets). The hardness and diameters of the produced tablets were measured by the hardness tester
TBH 125 (ERWEKA® D-63150 GmbH, Heusenstamm, Germany, [52]) and the tablet thickness was
measured by caliper.
Index of elastic recovery (ER, %), ejection stress (ES, MPa) and tensile fracture stress (TFS, MPa)
are the main estimated technological quality-by-design parameters used for assessing performance of
tableting processes and tablet quality. These tableting characteristics are sensitive to both, material
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characteristics (i.e., flowability, particle size distribution, moisture content, particle shape and fabrics,
porosity, crystallinity, surface area and charge) and compaction process attributes (i.e., the initial load
and punch speed settings [42,55,57]). ER value is used to measure the material elasticity, which is the
ability to reduce its volume (i.e., measuring the ability of the powder to return to its original volume
when a compression load is removed). On ER profiles (displacement in m versus compression force in
N), ER% values were calculated by using the following equation:
ER% = 100(hb − ha)/hb (1)
where hb is the in-die tablet thickness under compression (mm), which was calculated as the difference
value between the die base plate position (= 28.348 mm) and the deepest punch position within the die
(i.e., at the displacement corresponding to the point b), and ha is the decompression tablet thickness
after elastic relaxation (i.e., at the displacement corresponding to the point a, when the compression
force becomes 0). The compression energy (N.m) values were calculated as the area under curve (AUC)
approach using trapezoidal rule by taking into account the force and displacement data below the
deepest punch position (Figure 1a).
The ES value is used to assess the powder manufacturability (i.e., tabletability), which expresses
the friction between the material and the equipment; hence it is strongly correlated with manufacturing
problems (i.e., tablet failures such as capping and lamination or powder sticking to punch surfaces or
die wall). On the ES profiles (displacement in mm versus ejection force in N), ES values were estimated
by applying the following equation:
ES (MPa) = Fmax/(pi × d × hb) (2)
where Fmax is the maximum ejection force (N), d is the die diameter (=6 mm), and hb is the compression
tablet thickness under maximum pressure (mm). The detachment stress values were calculated on its
profile (displacement in mm versus detachment force in N) by the following equation:
ES (MPa) = Fmax/A (3)
where Fmax is the maximum detachment force (N), A is the area of contact circle (= 9 pi mm2). Both of
the ejection and detachment energies (N.m) were also calculated by applying the AUC approach
(Figure 1b,c). TFS value is used to assess the powder compactability, which is the ability to form
interparticular bonds, and it is determined by using the following equation:
TFS (MPa) = 2H/(pi × D × T) (4)
where H is the tablet hardness (in N), D is the tablet diameter (in mm), and T is the out-of-die tablet
thickness (in mm).
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Figure 1. Representative average data of tableting profiles: (a) compression; (b) detachment and;
(c) ejection processes.
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3. Results and Discussion
3.1. Powder Characteristics
3.1.1. Compostion and Microstructure
Samples N-2, K-3, F-2 and D-6 were highly pure, with kaolinite contents of 99%, 95%, 98% and
98%, respectively. The Al2O3/SiO2 ratios of the bulk kaolin samples were found very close to the
stoichiometric ratio (0.85) of the theoretical kaolinite, except in sample K-3 which was slightly influenced
by the illite content [38]. Mineral impurities, especially the quartz contents, were detected as traces,
which comply with the safety limits of human toxicological specifications (Figure 2 and Table 1, [58]).
The samples were also analyzed by using Coupled Plasma Optical Emission Spectrometry (ICP-OES)
and Instrumental Neutron Activation Analysis (INAA) and showed no contents of the toxic Class 1
(As, Cd, Hg and Pb) elemental impurities, while their contents from Class 2A (Co, Ni and V) and Class
3 (Cu and Cr) metals were very low and lay within the safe limits of the oral Permitted Daily Exposure
(PDE), according to the European Medicines Agency [59]. The studied purified kaolin samples meet
the international pharmacopeial specifications for the pharmaceutical kaolin grade.
Figure 2. X-ray diffractograms showing kaolinite structural changes between the precursor (dried at
70 ◦C) and the dehydrated (heated up to 400 ◦C) kaolin powders.
Normally kaolinite Al2Si2O5(OH)4 is thermally stable up to ~450 ◦C, considered as the starting
point of dehydroxylation, and then it can be transformed to metakaolinite (Al2Si2O7) at 650 ◦C, which
is variable based on kaolinite order-disorder degrees [60]. No significant phase transformations
occurred in the studied kaolin samples after thermal treatment by heating up to 400 ◦C, but only
some deformations observed to the widths, lengths and backgrounds of the kaolinite XRD reflections
within the range 19–24◦ 2θ, which imply microstructural thermal changes (Figure 2). The calculated
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HI values of samples N-2, K-3, F-2 and D-6, dried at 70 ◦C, were 1.50, 1.33, 0.45 and 0.27, respectively,
changing to 0.91, 0.83, 0.59 and 0.48 when heated up to 400 ◦C, respectively. The average crystallite sizes
(D001) slightly changed from 44, 39, 31 and 30 nm, respectively, to 37, 34, 26 and 25 nm, respectively
(Figure 3 and Table 2). Both, the crystallite size and order-disorder degrees of kaolinite, are two strongly
correlated microstructural characteristics (Figure 3) and sensitive to the thermal effect. The thermal
treatment at 400 ◦C probably causes deformation and/or exfoliation of the stacked kaolinite platelets, as
it is observed by the lowering of HI “crystallinity” in the typically well-crystallized and high ordered
kaolinite samples (HI > 1) accompanied with a decrease of their crystallite size, while it slightly
improved their order degree [61] along the c-axis in the disordered ones (HI < 1).
Figure 3. Relationship between kaolinite structural characteristics with observed shifting upon
thermal changes.
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Table 1. Chemical and mineralogical compositions of the purified kaolin powder samples.
Sample SiO2 Al2O3 TiO2 Fe2O3 MgO CaO Na2O K2O LOI
Al2O3/
SiO2
Kaolinite % Illite % Quartz % Anatase %
N-2 43.11 36.82 1.1 0.60 0.13 0.04 0.26 0.01 17.91 0.85 99 - - 1
K-3 43.13 35.85 0.5 0.54 0.18 0.04 0.26 0.44 18.99 0.83 95 3 1 1
F-2 43.04 36.84 1.2 0.74 0.06 0.06 0.04 0.01 17.92 0.85 98 - 1 1
D-6 42.86 36.41 1.12 0.71 0.06 0.04 0.08 0.02 18.57 0.85 98 - 1 1
LOI: loss on ignition.
Table 2. Kaolinite structural characteristics (crystallite size and order-disorder degree), bulk and tapped density values and flowability parameters of the studied dried
(at 70 ◦C) and dehydrated (at 400 ◦C) kaolin powders.
Sample
Code
Heating
Conditions
Crystallite Size
D001 (nm)
Hinckley
Index
Bulk Density
(g/mL) ± 0.01
Tapped Density
(g/mL) ± 0.01
Direct Flowability
(g/s) ± 0.1
Carr’s
Index ± 0.01
Hausner
Ratio ± 0.01
Flow
Character
N-2
70 ◦C (2 h) 44 1.50 0.55 0.81 2.64 32.00 1.47 Poor
400 ◦C
(10 ◦C/min) 37 0.91 0.66 0.76 3.74 12.50 1.14 Good
K-3
70 ◦C (2 h) 39 1.33 0.51 0.81 2.05 36.67 1.58 Poor
400 ◦C
(10 ◦C/min) 34 0.83 0.66 0.71 2.56 8.00 1.09 Excellent
F-2
70 ◦C (2 h) 31 0.45 0.64 0.83 2.06 22.50 1.29 Very poor
400 ◦C
(10 ◦C/min) 26 0.59 0.64 0.75 3.51 15.38 1.18 Good
D-6
70 ◦C (2 h) 30 0.27 0.54 0.67 2.04 20.00 1.25 Very poor
400 ◦C
(10 ◦C/min) 25 0.48 0.50 0.62 3.85 19.17 1.24 Fair
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3.1.2. Microtexture and Micromorphology
SEM images indicated that the apparent sizes of kaolinite platy particles are mainly <4 µm for all
the studied kaolin powder samples. Clearly, the powder microtexture is appeared as loosely packing
of coarser aggregates in a planar alignment surrounded by the finer individual particles (Figure 4).
TEM images (upper right views of Figure 4) showed that the studied kaolinite platelets exhibited
equant to sub-elongate shape with little pseudohexagonal form, smooth surfaces, rounded anhedral to
subhedral edges, and contacted mainly by face-to-face. The individual platelets in all samples mainly
showed sizes <700 nm. The particle shape and packing manner influences the flow and compression
behaviors. In the regularly shaped particles, the smaller ones attend to rearrange more easily by
tapping or under compaction pressure by moving into the interparticle voids to be more tightly packed
and producing final volume reduction [62].
Figure 4. SEM and TEM (upper right views) images showing microtextural characteristics and particles
micromorphology of the studied kaolin powder samples.
3.1.3. Particle Size Distribution
Table 3 and Figure 5 show the particle size distribution (PSD) and grading characteristics (i.e.,
the geometric properties of the particle size grading curves) of the analyzed original kaolin powder
samples. The particle size uniformity were determined on the basis of the particle size values D10,
D50 and D90 and calculated by means of the span = (D90 – D10)/D50, which is the breadth of PSD
unimodal curve (i.e., the narrower the distribution, the smaller the span value), frequently used in
quantification and comparison of PSD homogeneity of pharmaceutical powders [63].
The laser granulometric data showed that all samples were dominated by the finer nanosized
particle fractions from 10 nm to 1 µm (ranging from 55.22% to 62.24%) followed by the microsized
particle fractions 1–10 µm (ranging from 35.9% to 40.33%) and then the coarser size fractions of particle
aggregates >10 µm which up to ~40 µm (ranging from 1.78% to 4.45%).
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Table 3. Particle size distribution, porosity and moisture content by TG (mass loss % within the
temperature range 25–400 ◦C) of the studied kaolin powder samples.
Sample
Code
Particle Size Distribution Cumulative
Pore Volume
(BJH) cm3/g
Mass Loss
TG %
(at 400 ◦C)
<1
µm
1–4
µm
4–10
µm
>10
µm
D10
µm
D50
µm
D90
µm Span
N-2 55.22 35.87 4.46 4.45 0.42 0.87 3.67 3.74 0.1360 −3.98
K-3 59.93 35.11 3.18 1.78 0.42 0.83 2.50 2.51 0.0640 −4.95
F-2 60.08 35.45 2.23 2.24 0.42 0.84 2.25 2.18 0.0951 −5.82
D-6 62.24 34.01 1.89 1.86 0.42 0.81 2.15 2.14 0.1096 −2.98
Clearly, the median particle size (D50) values of all the measured powder samples are ranging
from 0.81 to 0.87 µm, while 90% of their whole particle sizes (D90) are <4 µm (Table 3). In general,
all the powder samples showed similar distributions and median particle sizes (D50), complying with
those of pharmaceutical grade kaolin [64]. Samples with the higher disordered kaolinite exhibited the
highest contents of the finer particle size fractions: D-6 (lowest HI values) contains 62.24% of the finest
particle size fraction (<1 µm) which decreased towards sample N-2 (highest HI values) that exhibited
55.22% of this fraction (Table 3).
Figure 5. Laser volume-based particle size distribution frequency and cumulative curves of the studied
kaolin powder samples.
In addition to the particle shape, the size is the other most important factor for powder flowability
and tableting performance. Generally, the larger particles exhibit the higher mass and hence yield
the better flow due to the effect of their higher gravitational force. Kaolinite exhibits higher particle
density (true density is 2.65 g/cm3 [65]) when compared with those of the other common excipient
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materials like maize starch (true density is 1.10 g/cm3 [66]) and microcrystalline cellulose (true density
is 1.42–1.66 g/cm3 [67]). Hence, the kaolin powder flow especially increases as the homogeneity of
PDS increases, either by the relative reduction of the coarser aggregate fractions, or by cohesiveness
of the ultrafine particles (<1 µm), producing uniform sized agglomerates in order to optimize
the PSD as indicated by lower span values. Nevertheless, the over-reduction of size increases
the inter-particle cohesiveness, the segregation of particles decreases and the flow diminishes [68].
Therefore, the narrower size distribution yields the better flow performance, while the wider size
distribution could lead to reduced powder flow and influence the content uniformity during tablet
manufacturing. At the same compaction pressure, smaller particles formed tablets of greater tensile
strength [69–71].
In the studied samples, the homogeneity of particle size distributions was raised (i.e., indicated
by reduction of the span values) with increasing of the finer size fractions (<1 µm): sample N-2
showed the lowest content (55.22%) of the finer fraction and the wider size distribution (the span vale
is 3.74), while sample D-6 exhibited the narrower size distribution (the span value is 2.14) and the
highest content (62.24%) of the finer size fraction (Table 3). The coarser kaolinite agglomerates (>4 µm)
can be disaggregated into smaller individual kaolinite platelets under controlled dry grinding and
sieving processes to obtain optimum homogeneous fine particle size fractions with smaller span values.
Nevertheless, these fine size fractions are frequently accompanied with lesser amounts of agglomerated
particles which can be gently disaggregated into smaller particles by the effect of interparticle sliding
frictions and vibrational collisions during the powder flow or recovered by milling processes.
3.1.4. Porosity and Pore Size Distribution
Table 3 and Figure 6 are showing the pore size distribution, porosity gradients and the
cumulative pore volume (cm3/g) of the measured kaolin powder samples. According to the IUPAC
nomenclature [72], the BJH porosity data indicated that the studied powders exhibited mesoporous
character as they containing pores with diameters ranged between 2 and 38 nm. Sample N-2 showed
the largest total pore volume (0.136 cm3/g) and greater pore gradient followed. Powder porosity is
normally controlled by the variability of particle size ranges, particle morphology and the manner of
their packing structure. In the studied samples, dominated by finer size fractions (90% of all particles
are <4 µm) distributed in the interstices between the coarsest particles, BJH values are small. Porosity,
porosity gradient and pore size distribution represent some of the variables that most influence the
tablet strength. The tensile strength decreases exponentially with increasing porosity for all size
fractions [70,73,74].
Figure 6. BJH-measured pore size distribution cumulative curves of the studied kaolin powder samples.
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3.1.5. Moisture Content by Thermogravimetry
Noticeably, the moisture contents of the analyzed kaolin samples (as enriched by kaolinite and
not accompanied with other hydrous minerals, except 3% illite in sample K-3 which is represented by
~0.36% LOI) can be observed as implied in the difference between the loss on ignition (LOI) values
(ranged between 17.91% and 18.99%, Table 1) and the theoretical water content of kaolinite (13.96%).
Kaolinite is the most thermally stable amongst clay minerals and when compared with other common
pharmaceutical materials at relatively high temperatures, normally up to 400 ◦C. Consequently, TGA is
a suitable approach of great value for quantifying moisture contents of kaolin powder excipient,
as it is a more accurate and rapid method for quality-by-design in pharmaceutical formulations.
Simultaneous thermal analyses (TGA/DTA) have been employed for determining mass losses and
moisture contents, evaluating the thermal stability and identifying the phase transformations of
pharmaceutical excipients [75–77].
In the thermal curves (Figure 7), the mass loss was steadily increased from the room temperature
(~25 ◦C) until the inflection point (the base temperature) that occurred at 450 ◦C for samples N-2,
K-3 and F-2, while appeared at 400 ◦C for sample D-6. The adsorbed water on kaolinite particles was
completely loss during this range. The moisture contents were determined from the dehydration
curves (Figure 8), represented by mass losses of 3.98%, 4.95%, 5.82% and 2.98% in samples N-2, K-3, F-2
and D-6, respectively (Table 3). Then, beyond the inflection point (400–450 ◦C), it was the beginning of
dehydroxylation process (i.e., the rapid loss of the structural water (−OH) from the aluminol surface,
indicated by great mass loss rate on the TG curves with endothermic peaks on the DTA curves).
Figure 7. Dehydration-dehydroxylation thermograms (TG%) and differential thermal analysis (DTA)
curves of the studied kaolin powder samples (25–400 ◦C).
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Figure 8. Dehydration thermal mass balance curves indicating moisture contents and mass loss rates
(TG%) of the measured kaolin powder samples (25–400 ◦C).
Under the used heating conditions (25–400 ◦C), kaolinites did not undergo significant phase
transformational changes, but only some structural changes existed as indicated on the kaolinite XRD
diffraction profiles (Figure 2). TG and DTA curves (Figure 7) are not identical for all the measured
samples, indicating different moisture contents and mass loss rates. These different behaviors depend
on the initial kaolinite order-disorder degrees [78,79] but also they can be attributed to differences
in particle sizes and pore size distributions of the samples. The studied kaolin powders showed
improvements in their flowability (Table 2) that could be attributed to these thermal-based structural
and microtextural changes accompanied with the observed mass loss (Figure 8).
3.1.6. Flow Characteristics
Heating kaolinite to 400 ◦C is most probably leading to shrinkage and disintegration of aggregated
particles due to the removal of the water adsorbed on particle surfaces, which affect interparticle forces
and decreases particle friction and cohesion, facilitating particle rearrangement and causing changes in
powder density, and hence the increasing of flowability (i.e., the HR values are reduced [80], Figure 9
and Table 2).
3.2. Tableting Characteristics
It is reported that during the powder compaction process into a tablet, the particles undergo
four connected events: rearrangement according to size, shape and density; plastic deformation
and/or fragmentation; elastic compact deformation; and elastic recovery when the pressure is removed
(unloading) as the tablet is relaxed into its final dimensions. Normally, plastic or elastic particles deform
to accommodate the increasing applied force, while brittle particles break into smaller fragments
which then displace the pores. The tableting behavior is evaluated on the basis of powder success to
form a coherent compact with a measurable strength and without particle adhesion to the equipment
(i.e., punch and die wall [42]). Structurally, each kaolinite particle in the overall kaolin powder is
composed of aggregated platelets. Each individual platelet exhibits a sheet-like structure of stacked
tetrahedral-octahedral T–O layers along the crystallographic c-axis, which may exhibit ordered or
disordered growths (i.e., well-crystallized and poorly-crystallized kaolinites, respectively), and have
large or small maximum coherent thickness of the T–O layers, known by crystallite size (D001 in
nm [39]). Particle size increases with temperature due to platelet-platelet adhesion by the effect of
inter-particulate forces (electrostatic and van der Waals) among the kaolinite platelet surfaces and
edges of different charges, with removal of the adsorbed water, which lead to the clustering of the
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ultrafine kaolinite platelets (<1 µm) by face-to-face and edge-to-edge adhesions into larger aggregated
particles (Figure 4 [65]).
Figure 9. The relationship between the flow parameters HR versus CI of the studied kaolin powders,
showing significant flowability improvements with the thermal effect.
The interrelated structural characteristics of kaolinite (HI and D001) define the final particle
geometric dimensions by means of the shape and size of aggregates. Kaolin powders enriched
in well-crystallized and large crystallite-size kaolinites (samples N-2 and K-3), when dominated
by ultrafine particles of nanosized diameters, yield particle aggregates of relatively more equant
dimensions and more sphericity with smoother surfaces than those yielded by the kaolin powders
enriched in the poorly-crystallized kaolinites (samples F-2 and D-6) at similar size ranges and contents
of the ultrafine particle fractions (<1 µm). The heating of kaolin powders at 400 ◦C (10 ◦C/min)
generally optimizes the particle size uniformity and homogeneity, enhances the flowability, facilitates
particle rearrangement and minimizes adhesive forces with the surfaces of the equipment during the
compaction process, producing successful tablets with measurable hardness (H) values from 33 to 44 N,
in the order K-3 < N-2 < F-2 < D-6 (Table 4). Tableting failures were observed in all kaolin powder
sample categories prepared either by dryness at 70 ◦C, due to powder sticking to punch surfaces and
die wall, or in those heated at dehydroxylation high-temperature (>400 ◦C) by capping and fracturing.
Table 4. Tableting parameters estimated to each seven tablets manufactured from the four representative
kaolin powder samples.
Tableting and Tablet
Parameters N-2 K-3 F-2 D-6
Commercial
Kaolin
Elastic Recovery (%)
“Compressibility” 25.61 ± 0.19 25.43 ± 0.18 23.51 ± 0.11 21.74 ± 0.21 30.92 ± 0.21
Ejection Stress ES (MPa)
“Manufacturability” 8.28 ± 0.03 7.85 ± 0.17 8.67 ± 0.16 11.45 ± 0.15 4.01 ± 0.17
Tensile Fracture Stress TFS
(MPa) “Compactability” 2.04 ± 0.02 1.85 ± 0.02 2.09 ± 0.02 2.32 ± 0.02 1.16 ± 0.04
Compression Energy Ec (N.m) 1.88 ± 0.01 1.83 ± 0.01 1.81 ± 0.01 1.99 ± 0.04 1.58 ± 0.02
Detachment Stress DS (MPa) 8.19 ± 0.02 7.61 ± 0.03 9.56 ± 0.04 8.65 ± 0.03 8.24 ± 0.07
Detachment Energy ED (N.m) 1.80 ± 0.01 1.71 ± 0.02 1.93 ± 0.04 1.80 ± 0.03 0.76 ± 0.06
Ejection Energy (N.m) 0.26 ± 0.01 0.23 ± 0.03 0.34 ± 0.03 0.43 ± 0.05 0.07 ± 0.01
Tablet Hardness H (N) 36.67 ± 0.4 33.00 ± 0.7 38.33 ± 0.58 44.00 ± 0.7 18.67 ± 0.58
Tablet Diameter (mm) 6.02 ± 0.01 6.04 ± 0.03 6.04 ± 0.01 6.05 ± 0.02 6.03 ± 0.02
Tablet Thickness (mm) 1.9 ± 0.01 1.88 ± 0.03 1.93 ± 0.06 2.00 ± 0.01 1.70 ± 0.01
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Well crystallized kaolinite-enriched kaolin powder showed higher flowability (low HR value)
and produced the highest elastic recovery tablets, with relatively better manufacturability (lower ES
values toward the ideal limits < 5 MPa) with good compactability (TFS values ≥ 2 MPa [57], Figures 10
and 11).
Figure 10. Mutual interrelationships of the tableting parameters (ER, ES, TFS) and against tablet
hardness (H) of the studied compressed kaolin powder samples.
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Figure 11. Influence of kaolinite crystallinity (HI) and flowability (HR) on the tableting properties of
the studied kaolin powder samples.
ER values increased from 21.74% (D-6) to 25.61% (N-2) in the order D-6 < F-2 < K-3 < N-2,
indicating strong negative correlations with H, ES and TFS. ES values ranged from 7.85 MPa (K-3) to
11.45 MPa (D-6). TFS values ranged from 1.85 MPa (K-3) to 2.32 MPa (D-6). The goodness degrees of
powder manufacturability (ES) and compactability (TFS) were increased in the order K-3 < N-2 < F-2 <
D-6. They showed a strong positive correlation among them, and also with H values (Figure 10 and
Tables 4 and 5).
Therefore, kaolin particles exhibit appropriate plasticity and elasticity for compactness.
The dehydration of adsorbed water on the kaolinite particle surfaces by heating at the used optimum
thermal conditions, the increase of particle size, homogeneity and sphericity by pelletization or
granulation processes, as well as the addition of adequate and compatible glidants and/or lubricants,
can affect interparticle forces, thus minimizing particle-particle frictions and particle-wall adhesion,
to facilitate particle rearrangement and to improve flowability and enhancements of the tabletability
performance in the studied kaolin powders.
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Table 5. Correlation matrix showing all the interrelated structural, micrometric, moisture, flowability and tableting parameters of the studied kaolin powder samples.
Parameters ER ES TFS H Ec HR CI D50 Span PSD < 1 µ % HI D001 TG% BJH
ER 1.00
ES −0.92 1.00
TFS −0.89 0.93 1.00
H −0.92 0.95 1.00 1.00
Ec −0.65 0.89 0.80 0.80 1.00
HR −0.93 0.92 0.99 0.99 0.71 1.00
CI −0.90 0.88 0.98 0.98 0.68 0.99 1.00
D50 0.75 −0.68 −0.42 −0.49 −0.47 −0.48 −0.40 1.00
Span 0.72 −0.47 −0.32 −0.38 −0.09 −0.44 −0.39 0.88 1.00
PSD < 1 µ % −0.79 0.63 0.43 0.50 0.33 0.51 0.45 −0.97 −0.96 1.00
HI 0.98 −0.82 −0.79 −0.83 −0.47 −0.86 −0.84 0.77 0.83 −0.84 1.00
D001 0.93 −0.72 −0.71 −0.75 −0.33 −0.80 −0.78 0.73 0.86 −0.84 0.99 1.00
TG% 0.39 −0.72 −0.61 −0.61 −0.95 −0.50 −0.46 0.27 −0.17 −0.09 0.19 0.03 1.00
BJH −0.08 0.28 0.52 0.46 0.44 0.43 0.49 0.52 0.62 −0.55 0.07 0.15 −0.50 1.00
ER: elastic recovery (%); ES: ejection stress (MPa); TFS: tensile fracture stress (MPa); H: tablet hardness (N); Ec: compression energy (N.m); HR: Hausner Ratio; CI: Carr’s Index; D50: the
median particle size; Span: particle size homogeneity assessment parameter [span = (D90 − D10)/D50]; PDS < 1 µ %: contents of the finer nanosized particle fractions; HI: Hinckley Index;
D001: crystallite size; TG %: thermogravimetric mass loss % within temperature range 25–400 ◦C; BJH: cumulative pore volumes (cm3/g) determined by Barrett, Joyner and Halenda method.
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4. Conclusions
The studied pharmaceutical grade kaolin powders proved that kaolinite, beside its ubiquity,
biological safety and good surface properties, is a promising compressible and compactable excipient
material in the formulations of tablet solid dosage forms. The effects of temperature (up to 400 ◦C)
can maintained the interrelated structural crystallinity and crystallite size, micrometric and cohesive
properties of kaolinite particles, as the most thermal stable clay mineral, and hence led to improving
the flowability of kaolin powders. Kaolinite order-disorder degree, thickness of structural T-O layer
stacking along c-axis (measured by Hinckley crystallinity Index HI and crystallite size D001) and powder
flowability (measured by Carr´s Index CI and Hausner Ratio HR) have been found to be strongly
correlated with the mechanical and quality-by-design properties (elastic recovery %, ejection stress
MPa and tensile fracture stress MPa) of the kaolin powders that control their tableting characteristics
(elasticity, manufacturability and compactability) and tablet hardness. Therefore, the removal of water
adsorbed on kaolinite particle surfaces by the effect of heat, with addition of adequate glidants and/or
lubricants, can affect interparticle forces, thus decreasing particle friction and cohesion, and facilitate
particle rearrangement, causing changes in powder density that increases kaolin powder flowability
and tabletability.
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